基于微珠多重免疫分析法对抗因子VIII抗体进行全面的结构域特异性分析及免疫球蛋白G谱分析
本研究评估了一种基于Luminex微珠的实验室自建方法(LumiTope),与商用ELISA和Nijmegen-Bethesda法(NBA)比较,用于检测血友病A患者的抗因子VIII抗体。LumiTope总体灵敏度94.9%、特异度91.2%,在低滴度抑制物患者中优于ELISA。NBA阳性患者以IgG4亚类为主,不同基因变异患者呈现不同的结构域抗体谱。
要点
- LumiTope法总体灵敏度94.9%、特异度91.2%,低滴度抑制物患者中优于ELISA。
- NBA阳性患者中IgG4为最丰富的IgG亚类。
- 重型链基因变异患者抗体主要针对重链,轻链变异患者抗体分布更多样。
核心结论
- LumiTope法为抗FVIII抗体的检测及结构域特异性分析提供了灵敏且特异的方法。
- 基于微珠的方法可改善抗体检测、谱分析及结果可比性,并补充NBA。
研究设计与样本
- 评估实验室自建Luminex微珠法(LumiTope)与商用ELISA及Nijmegen-Bethesda法(NBA)的比较。
- LumiTope包含全长及B结构域缺失FVIII以及9种纯化的FVIII单一或多结构域蛋白,偶联至磁珠检测结构域特异性IgG(IgG1-4)抗FVIII抗体。
- 在伴有和不伴有抑制物的大型血友病A患者队列中检测。
主要发现
- LumiTope法总体灵敏度94.9%、特异度91.2%。
- 在低滴度抑制物患者中LumiTope灵敏度94.9% vs ELISA灵敏度72.2%;另一比较中LumiTope灵敏度94.9% vs ELISA灵敏度27.7%。
- NBA阳性患者中IgG4为最丰富的IgG亚类。
- NBA阳性与阴性患者显示不同的结构域抗体谱。
- 重链基因变异患者主要表现针对重链的特异性抗体,轻链变异患者抗体特异性分布更多样;内含子22倒位患者与轻链缺陷患者相似,多数抗体靶向轻链。
关键数值与推荐
- LumiTope总体灵敏度94.9%、特异度91.2%。
- 低滴度抑制物患者中LumiTope灵敏度94.9% vs ELISA灵敏度72.2%。
- 另一比较中LumiTope灵敏度94.9% vs ELISA灵敏度27.7%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antibodies against factor (F)VIII are a major complication in the treatment of patients with severe hemophilia A. The Nijmegen-Bethesda assay (NBA) is the gold standard for detection of neutralizing antibodies (inhibitors), whereas both inhibitors and nonneutralizing antibodies can be detected by immunoassays such as enzyme-linked immunosorbent assay (ELISA) and multiplex bead-based assays. OBJECTIVES: Evaluation of an in-house Luminex bead-based assay (LumiTope) compared with a commercially available ELISA and NBA. METHODS: The LumiTope method comprised full-length and B-domain-deleted FVIII as well as 9 purified FVIII single or multidomains. The respective proteins were coupled to magnetic beads to detect domain-specific immunoglobulin (IgG; IgG1-4) anti-FVIII antibodies in a large cohort of patients with hemophilia A with and without inhibitors. RESULTS: Overall, LumiTope assay had a high sensitivity (94.9%) and specificity (91.2%), particularly in patients with low-titer inhibitors compared with ELISA (sensitivity of 72.2% vs 27.7%). IgG4 was the most abundant IgG subclass in NBA-positive patients. NBA-positive and -negative patients showed different domain profiles. Patients with genetic variants in the heavy chain predominantly exhibited antibodies specific to this chain, while those with a light-chain variant showed a more diverse distribution of antibody specificities. Patients with an intron 22 inversion resembled those with a light-chain defect, with a majority of antibodies targeting the light chain. CONCLUSION: LumiTope assay provides a sensitive and specific method for not only detection but also domain specification of anti-FVIII-antibodies. Implementation of bead-based assays could improve antibody detection, profiling, and comparability of results and complement NBA.
引用
- Pezeshkpoor B, Berkemeier AC, Herbst K, et al. Comprehensive domain-specific analysis and immunoglobulin G profiling of anti-factor VIII antibodies using a bead-based multiplex immunoassay. J Thromb Haemost. 2024. PMID: 38453023. doi:10.1016/j.jtha.2024.02.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。